» Articles » PMID: 34812607

Novel Positron Emission Tomography Radiotracers for Imaging Mitochondrial Complex I

Overview
Specialty Neurology
Date 2021 Nov 23
PMID 34812607
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dysfunction has been indicated in neurodegenerative and other disorders. The mitochondrial complex I (MC-I) of the electron transport chain (ETC) on the inner membrane is the electron entry point of the ETC and is essential for the production of reactive oxygen species. Based on a recently identified β-keto-amide type MC-I modulator from our laboratory, an F-labeled positron emission tomography (PET) tracer, , was prepared. PET/CT imaging studies demonstrated that exhibited rapid brain uptake without significant wash out during the 60 min scanning time. In addition, the binding of was higher in the regions of the brain stem, cerebellum, and midbrain. The uptake of can be significantly blocked by its parent compound. Collectively, the results strongly suggest successful development of MC-I PET tracers from this chemical scaffold that can be used in future mitochondrial dysfunction studies of the central nervous system.

Citing Articles

Innovations in Nuclear Medicine Imaging for Reactive Oxygen Species: Applications and Radiopharmaceuticals.

Park J, Park S, Lee T, Lee S, Kim J, Oh S Antioxidants (Basel). 2024; 13(10).

PMID: 39456507 PMC: 11504556. DOI: 10.3390/antiox13101254.


Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome.

Biby S, Mondal P, Xu Y, Gomm A, Kaur B, Namme J ACS Chem Neurosci. 2024; 15(19):3576-3586.

PMID: 39297418 PMC: 11450741. DOI: 10.1021/acschemneuro.4c00512.

References
1.
Mansur A, Rabiner E, Tsukada H, Comley R, Lewis Y, Huiban M . Test-retest variability and reference region-based quantification of F-BCPP-EF for imaging mitochondrial complex I in the human brain. J Cereb Blood Flow Metab. 2020; 41(4):771-779. PMC: 7983506. DOI: 10.1177/0271678X20928149. View

2.
Biffi A, Sabuncu M, Desikan R, Schmansky N, Salat D, Rosand J . Genetic variation of oxidative phosphorylation genes in stroke and Alzheimer's disease. Neurobiol Aging. 2014; 35(8):1956.e1-8. PMC: 4329419. DOI: 10.1016/j.neurobiolaging.2014.01.141. View

3.
Marshall R, Reutter B, Taylor S, VanBrocklin H, Huesman R, Budinger T . Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi. J Nucl Med. 2001; 42(2):272-81. View

4.
Swerdlow R, Khan S . A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med Hypotheses. 2004; 63(1):8-20. DOI: 10.1016/j.mehy.2003.12.045. View

5.
Terada T, Therriault J, Kang M, Savard M, Pascoal T, Lussier F . Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease. Mol Neurodegener. 2021; 16(1):28. PMC: 8074456. DOI: 10.1186/s13024-021-00448-1. View